We developed a glaucoma-on-a-chip (GOC) model to evaluate the viability of retinal ganglion cells 12 (RGCs) against high pressure and the potential effect of neuroprotection. A three-layered chip consisting 13 of interconnecting microchannels and culture wells was designed based on simulation of physical 14 parameters. The chip layers were fabricated from poly-methyl methacrylate sheets. Multiple inlet ports 15 allow culture media and gas into the wells under elevated hydrostatic pressure (EHP). The bottom surface 16 of the wells was modified by air plasma and coated with different membranes to model an extracellular 17 microenvironment. The SH-SY5Y neuroblastoma cell line served as model cells to determine the best 18 supporting membrane which was revealed to be PDL/laminin. Thereafter, the study experiments were 19 performed using RGCs obtained from postnatal 5-7 Wistar rats purified by magnetic assisted cell sorting.
Neurobasal medium was added to each well and incubated overnight at 37˚C (8% CO2). The 146 laminin/Neurobasal solution was replaced with 500 µl of "retinal ganglion cell media" which was prepared 147 as follows: Neurobasal medium (Gibco-BRL Life Technologies) with 1% bovine serum albumin (BSA, 148 Sigma-Aldrich), sodium selenite (6.7 ng ml -1 , Sigma-Aldrich), Insulin-Transferrin-Selenium (ITS-G) 149 (100X) (Thermo Fisher Scientific, Grand Island, New York, USA), progesterone (20 nM; Merck Millipore), 150 B27 Supplement (50X) (Thermo Fisher Scientific), sodium pyruvate (1 mM; Merck Millipore), L-151 Glutamine (100x) (2 mM; Gibco-BRL Life Technologies), penicillin (20 U ml -1 ), and streptomycin (20 mg 152 ml -1 ). 153 In accordance with the regulations of association for research in vision and ophthalmology (ARVO) for 154 animal studies, ten postnatal day's five to seven Wistar rats (Razi Institute, Karaj, Iran) were sacrificed by 155 decapitation and then enucleated. The cornea, lens, and vitreous humor were removed and the retina was 156 gently lifted away using a small spatula. The retinas were stored at room temperature in 4.5 ml Hank's 157 balanced salt solution, Ca2+ and Mg2+ free (HBSS-CMF, Sigma-Aldrich), pH 7.4. Then, 0.5 ml of trypsin 158 (2.5%, Gibco-BRL Life Technologies) was added to the tube containing five retinas and incubated in a 159 water bath at 37˚C for 15 min where the tube was gently swirled every 5 min. The HBSS/trypsin solution 160 was replaced by 5 ml of HBSS (containing 50 µl of DNase I 0.4%) and incubated at 37˚C for 5 min. The 161 retina was converted into a cell suspension by triturating and homogenizing the solution without introducing 162 bubbles. The cells were centrifuged at 300g for 5 min and re-suspended in 1ml HBSS containing 0.5 mg 163 ml -1 BSA. The cell suspension was filtered through a mesh filter (pore size 40 µm, BD Falcon, Franklin 164 Lakes, NJ) to yield a single cell suspension. 165 For magnetic assisted cell sorting (MACS), a concentration of 10 7 retinal cells per 90 µl of DBPS/BSA 166 buffer (Dulbecco's PBS containing 0.5 mg ml -1 BSA) was incubated with 10 µl of the RGC-specific marker 167 CD90.1 microbeads (Miltenyi Biotec, GmbH, and Bergisch Gladbach, Germany) at room temperature for 168 30 min and then washed with 5 ml of DPBS/BSA buffer. The cell suspension was passed through an LS 169 column to hold the micro bead-labelled cells (RGCs) in the magnetic field of a MidiMACS system (Miltenyi Biotec). The adherent RGCs were rinsed with 3 ml of DPBS/BSA buffer to deplete endothelial 171 cells and microglia. The column was removed from the separator and held over a new 15-ml tube. The 172 adhered cells were flushed out by firmly pushing the plunger into the column and counted. In different isolation steps, cells were stained with mouse anti-CD90.1 antibody (Millipore, Bedford, 175 MA) and goat anti-mouse IgG antibody FITC conjugated (Santa Cruz Biotechnology, Inc., Dallas, USA) 176 as primary and secondary antibodies, respectively. The anti-CD90.1 antibody was added to the cell 177 suspension at a concentration of 0.1 μg per 100 µl for 10 6 cells and incubated at 4˚C for 20 min. The cells 178 were washed three times with PBS buffer and then 100 µl anti-mouse IgG antibody FITC conjugated was 179 added (1:100 dilution) and incubated at room temperature for 30 min in the dark. After 3-times washing, 180 the fluorescence emission intensity was measured using a flow cytometer. FlowJo (Tree Star, Inc., Ashland,
181
OR) was used to exclude dead cells from the analysis based on scatter signals. The number of cells 182 exhibiting CD90.1 were manually counted, and the RGC percentage was calculated by determining the rate 183 of CD90.1-positive cells relative to other ones.
184
Purified RGCs were cultured on a chip pre-coated with PDL/laminin at 37˚C and 8% CO2. After a 3-185 day culture, RGCs were fixed with cold methanol (-10˚C) for 10 min, dried, and then blocked with 300µl 186 of PBS containing 1% BSA for 20 min at room temperature. The cells were incubated with 10 µl mouse 187 anti-CD90.1 antibody (1:100 dilution) as a primary antibody overnight at 4 °C. RGCs were exposed to goat RGCs were seeded at an initial density of 10 4 cells per cm2 in two sets of 12-well chips prior to the 195 pressure experiment. RGCs were exposed to high hydrostatic pressures in a time-dependent manner for 6, 196 12, 24, 36 and 48 hours. BDNF (50 ng ml -1 ; Thermo Fisher Scientific, Waltham, USA) and RNYK peptide 197 (5 ng ml -1 ) were separately applied to RGCs in one chip under normal and the other elevated hydrostatic These experiments were repeated for at least three times to check the reproducibility of biologic effects. 205 All measured variables were described as mean ±SD. The three-layered chip was designed to allow inflow of cell culture media from feeding inlets in layer 214 A into the wells in layer B adjacent to layer C which acts the culture surface at the bottom of the wells (Fig.   215 1). We fabricated stand-alone feeding inlets for each well to let treat culture cells within the wells in an 216 individual manner. We initially devised two feeding ports per well in layer A (the results not shown). The 217 drawback to this design was inappropriate surface tension leading to an uneven distribution of the culture 218 media. We then shifted to a single feeding port at one extreme of the well and placed a gas inlet on the other 219 extreme to allow uniform liquid distribution. Locating the feeding port at the extreme end of the well 220 reduced shearing stress and avoided cellular detachment and necrosis in the mid-region of the well.
221
Based on simulation results, a hexagonal (divergent-convergent) well performed better than a 222 rectangular well. If the cells are seeded into a rectangular well, they mainly localize in the central zone due 223 to maximum velocity there influenced by boundary layers related to sidewalls ( Fig. 2A , red curve).
224
Whereas, velocity profile became more even in a divergent-convergent input due to the reduction cross 225 section area and mitigation of boundary layer effects ( Fig. 2B , blue curve), resulting in a homogeneous 226 flow velocity and cell distribution across the well at the feeding and seeding times, respectively. We 227 designed 12 wells in each chip for simultaneously RGCs treatment with different compounds per well 228 without any mixing of culture media or cells from one well to another via the gas channels during feeding 229 process. The gas channels necessarily had to be interconnected to provide the same level of pressure and 230 gas conditions to all wells within a chip. A single gas inlet was located for each chip which led to two 231 separate main channels with six branching sub-channels ( Fig. 2C ).
232
The bottom surface of the wells (layer C) were treated by air plasma to chemical modification and (Fig. 5 ).
262
The RGCs were identified by their morphology and immunofluorescence staining characteristics. One set of the chips was connected to a gas tank to apply elevated pressure at 33 mmHg, 273 while another chip were exposed to normal pressure at 15 mmHg. As summarized in Figure 6 , 274 the EHP system consisted of a compressed 8% CO2/92% air gas tank, which was placed just In the present study, we designed a glaucoma-on-a-chip system that provides continuous 323 hydrostatic pressure with ±0.1 mmHg variation under a temperature-controlled environment.
324
Our system was custom-made in agree with the pressurized chamber approach, thus, several other small molecules prior to assessment in animal models.
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